Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism

Last updated: April 4, 2025
Sponsor: The Foundation for Orthopaedics and Regenerative Medicine
Overall Status: Active - Recruiting

Phase

1

Condition

Autism

Autism Spectrum Disorder (Asd)

Treatment

AlloRx

Clinical Study ID

NCT05003960
SC-8-ATG-8-02
  • All Genders

Study Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Autism

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of Autism

Exclusion

Exclusion Criteria:

  • Active infection

  • Active cancer

  • Chronic multisystem organ failure

  • Pregnancy

  • Clinically significant Abnormalities on pre-treatment laboratory evaluation

  • Medical condition that would (based on the opinion of the investigator) compromisepatient's safety

  • Previous organ transplant

  • Seizure disorder

  • Hypersensitivity to sulfur

Study Design

Total Participants: 15
Treatment Group(s): 1
Primary Treatment: AlloRx
Phase: 1
Study Start date:
January 23, 2022
Estimated Completion Date:
December 01, 2027

Study Description

Studies have shown that stem cell treatment is safe and efficacious for the treatment of Autism. Patients with Autism will receive a single intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells. The total dose for the infusion will be 100 million cells. Patients will be evaluated within one month pre treatment and at 1, 6, 12, 24, 36, and 48 months post treatment for safety and efficacy.

Connect with a study center

  • Medical Surgical Associates Center

    St. John's,
    Antigua and Barbuda

    Active - Recruiting

  • Athens Beverly Hills Medical Group

    Glyfáda, Athens 16675
    Greece

    Active - Recruiting

  • Mediterraneo Hospital Ilias 8-12

    Glyfáda, Athens 16675
    Greece

    Active - Recruiting

  • Artros

    Ljubljana, 1000
    Slovenia

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.